These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1700400)

  • 1. Correlation of substance P-induced desensitization with substance P amino terminal metabolites in the mouse spinal cord.
    Igwe OJ; Sun X; Larson AA
    Peptides; 1990; 11(4):817-25. PubMed ID: 1700400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of substance P amino terminal metabolites in substance P-induced desensitization in mice.
    Igwe OJ; Sun X; Larson AA
    Neuroscience; 1990; 36(2):535-42. PubMed ID: 1699171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lysergic acid diethylamide (LSD) and adjuvant-induced inflammation on desensitization to and metabolism of substance P in the mouse spinal cord.
    Larson AA; Igwe OJ; Seybold VS
    Pain; 1989 Jun; 37(3):365-373. PubMed ID: 2474144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major metabolites of substance P degraded by spinal synaptic membranes antagonize the behavioral response to substance P in rats.
    Sakurada C; Watanabe C; Sakurada S; Tan-No K; Sakurada T
    J Pharm Sci; 1999 Nov; 88(11):1127-32. PubMed ID: 10564060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes.
    Igwe OJ; Kim DC; Seybold VS; Larson AA
    J Neurosci; 1990 Nov; 10(11):3653-63. PubMed ID: 1700082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses.
    Sun XF; Larson AA
    J Neurosci; 1991 Oct; 11(10):3111-23. PubMed ID: 1719157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
    Velázquez RA; Kitto KF; Larson AA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral activation of neurokinin-1 agonists in relation to enzymatic degradation in the spinal cord.
    Sakurada T; Yogo H; Tan-No K; Sakurada S; Kisara K
    J Pharm Sci; 1994 Jan; 83(1):2-4. PubMed ID: 7511162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of substance P(1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level.
    Sakurada C; Watanabe C; Sakurada T
    Methods Find Exp Clin Pharmacol; 2004 Apr; 26(3):171-6. PubMed ID: 15148521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception.
    Skilling SR; Smullin DH; Larson AA
    J Neurosci; 1990 Apr; 10(4):1309-18. PubMed ID: 1691775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord.
    Yukhananov RYu ; Larson AA
    Neurosci Lett; 1994 Aug; 178(1):163-6. PubMed ID: 7529387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P(1-7) antagonizes substance P-induced aversive behaviour in mice.
    Sakurada T; Kuwahara H; Takahashi K; Sakurada S; Kisara K; Terenius L
    Neurosci Lett; 1988 Dec; 95(1-3):281-5. PubMed ID: 2465511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoramidon potentiates mammalian tachykinin-induced biting, licking and scratching behaviour in mice.
    Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K
    Pharmacol Biochem Behav; 1990 Dec; 37(4):779-83. PubMed ID: 1709505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization to intrathecal substance P in mice: possible involvement of opioids.
    Larson AA
    Pain; 1988 Mar; 32(3):367-374. PubMed ID: 2452400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of substance P by intrathecal KK-3, a newly synthesized Leu-enkephalin derivative.
    Takahashi M; Tokuyama S; Kaneto H
    Pharmacol Biochem Behav; 1989 Aug; 33(4):843-6. PubMed ID: 2482510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord].
    Sun XC; Li WB; Li SQ; Li QJ; Chen XL; Ai J
    Sheng Li Xue Bao; 2003 Dec; 55(6):677-83. PubMed ID: 14695485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel receptor mediating substance P-induced behavior in the mouse.
    Mousseau DD; Sun X; Larson AA
    Eur J Pharmacol; 1992 Jul; 217(2-3):197-201. PubMed ID: 1385166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
    Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective and extremely potent antagonist of the neurokinin-1 receptor.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
    Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
    Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
    Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.